QVT-21109-52679
4 vaccinations
3 coded responses
40 check-ins
3 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 61-65
- ZIP prefix
- 554 / MN
- Registered
- 2021-01-30
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-30
Registered in v-safe
-
2021-01-30
Dose 1 — Pfizer-BioNTech
- 2021-01-30
- 2021-01-31
-
2021-02-01
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Redness, Swelling, Itching · Fatigue or tirednessAdult check-in
- 2021-02-02
- 2021-02-03
- 2021-02-04
- 2021-02-05
- 2021-02-06
- 2021-02-13
-
2021-02-19
Dose 2 — Pfizer-BioNTech
-
2021-02-20
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain, Itching · Fatigue or tiredness, NauseaAdult check-in
-
2021-02-21
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
- 2021-02-22
- 2021-02-23
- 2021-02-24
- 2021-02-25
- 2021-02-26
- 2021-03-05
- 2021-03-12
- 2021-03-19
-
2021-03-26
Survey response — day 35, dose 2MedDRA: Cough, Oropharyngeal pain — Feeling: GoodFree text: Cough and sore throatMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-04-04
- 2021-05-21
- 2021-08-20
-
2021-09-19
Dose 3 — Pfizer-BioNTech
- 2021-09-30
- 2021-10-03
- 2021-10-10
- 2021-10-17
- 2021-10-24
- 2021-10-31
- 2021-12-19
-
2022-03-20
Survey response — 6 months, dose 3MedDRA: Polypectomy, Uterine dilation and curettage, Vaginal haemorrhage — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit, Emergency room or emergency department visitFree text: Vaginal bleeding. Removal of polyps. D and CMedDRA releases: 2024-11 · check-in free text available
-
2022-03-20
Report sent to call center — 6 months, dose 3Be unable to do your normal daily activities · Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · Emergency room or emergency department visit · 1 call case(s)
- 2022-03-22
-
2022-05-04
Dose 4 — Moderna
- 2022-05-14
- 2022-05-18
- 2022-05-25
- 2022-06-01
- 2022-06-08
- 2022-06-15
- 2022-08-03
-
2022-11-02
Survey response — 6 months, dose 4MedDRA: COVID-19, Cough, Nasopharyngitis — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Covid and a bad cold and coughMedDRA releases: 2024-11 · check-in free text available
- 2023-05-04
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-30 | Pfizer-BioNTech | |
| 2 | 2021-02-19 | Pfizer-BioNTech | |
| 3 | 2021-09-19 | Pfizer-BioNTech | No |
| 4 | 2022-05-04 | Moderna | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2022-03-20 | Unsuccessful |
Free text
Release 6 — day 35, dose 2
Symptoms: Cough and sore throat
Release 11 — 6 months, dose 3
Symptoms: Vaginal bleeding. Removal of polyps. D and C
Release 12 — 6 months, dose 4
Symptoms: Covid and a bad cold and cough
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Cough | ✓ | ✓ | ✓ |
| SD | COVID-19 | · | · | ✓ |
| SD | Nasopharyngitis | · | · | ✓ |
| SD | Oropharyngeal pain | ✓ | ✓ | ✓ |
| SD | Polypectomy | · | · | ✓ |
| SD | Uterine dilation and curettage | · | · | ✓ |
| SD | Vaginal haemorrhage | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release